Literature DB >> 11223005

Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.

C Dentresangle1, M Le Cavorsin, M Savasta, V Leviel.   

Abstract

After injection of 6-hydroxydopamine into the lateral part of the rat substantia nigra, tissue dopamine (DA), dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) were reduced in the corresponding lateral part of the ipsilateral caudate/putamen (CP) complex (13, 40 and 56% of controls, respectively). In this region, tyrosine hydroxylase (TH, the rate limiting enzyme of the DA synthesis) immunoautoradiography decreased by more than 80% as was the case for the binding of tritiated GBR12935 (a specific marker of the DA-carrier protein). In the medial region of the CP, only very moderate reductions of DA, DOPAC and HVA (77, 76 and 84% of controls, respectively) were observed. In this region, TH immunoautoradiography and GBR12935 binding were only reduced by about 20% reflecting weak DA denervation. However, using in vivo voltammetry, extracellular basal DA levels were found to be particularly high in the medial region of CP complex when compared to unoperated animals (up to 235%). In the medial region, TH activity was also significantly increased (161%) but the electrical stimulation of DA fibers produced the same DA overflow in control and lesioned animals. From these results, it may be concluded that elevated basal DA levels in this region cannot be attributed to the reduced DA uptake and/or to an increased ability of DA neurons to release DA in response to impulse flow.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223005     DOI: 10.1016/s0006-8993(00)03311-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  High-frequency stimulation of the subthalamic nucleus prolongs the increase in striatal dopamine induced by acute l-3,4-dihydroxyphenylalanine in dopaminergic denervated rats.

Authors:  Emilie Lacombe; Carole Carcenac; Sabrina Boulet; Claude Feuerstein; Anne Bertrand; Annie Poupard; Marc Savasta
Journal:  Eur J Neurosci       Date:  2007-09-06       Impact factor: 3.386

2.  An integrative model of Parkinson's disease treatment including levodopa pharmacokinetics, dopamine kinetics, basal ganglia neurotransmission and motor action throughout disease progression.

Authors:  Florence Véronneau-Veilleux; Philippe Robaey; Mauro Ursino; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-10-21       Impact factor: 2.745

3.  Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.

Authors:  G Drui; S Carnicella; C Carcenac; M Favier; A Bertrand; S Boulet; M Savasta
Journal:  Mol Psychiatry       Date:  2013-02-12       Impact factor: 15.992

4.  Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.

Authors:  Christopher D Howard; David P Daberkow; Eric S Ramsson; Kristen A Keefe; Paul A Garris
Journal:  Eur J Neurosci       Date:  2013-04-11       Impact factor: 3.386

5.  Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.

Authors:  Giselle M Petzinger; John P Walsh; Garnik Akopian; Elizabeth Hogg; Avery Abernathy; Pablo Arevalo; Patty Turnquist; Marta Vucković; Beth E Fisher; Daniel M Togasaki; Michael W Jakowec
Journal:  J Neurosci       Date:  2007-05-16       Impact factor: 6.167

6.  Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease.

Authors:  Nicoletta Schintu; Lucia Frau; Marcello Ibba; Arianna Garau; Ezio Carboni; Anna R Carta
Journal:  Neurotox Res       Date:  2009-05-27       Impact factor: 3.911

7.  Dual use of immunohistochemistry for film densitometry and light microscopy.

Authors:  Miguel Melendez-Ferro; Matthew W Rice; Rosalinda C Roberts; Emma Perez-Costas
Journal:  J Neurosci Methods       Date:  2012-05-10       Impact factor: 2.390

8.  Computational studies of the role of serotonin in the basal ganglia.

Authors:  Michael C Reed; H Frederik Nijhout; Janet Best
Journal:  Front Integr Neurosci       Date:  2013-05-24

9.  Mathematical insights into the effects of levodopa.

Authors:  Michael C Reed; H Frederik Nijhout; Janet A Best
Journal:  Front Integr Neurosci       Date:  2012-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.